======= CHMP7 ======= == Gene Information == * **Official Symbol**: CHMP7 * **Official Name**: charged multivesicular body protein 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=91782|91782]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8WUX9|Q8WUX9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=CHMP7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHMP7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/611130|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: ESCRT-III-like protein required to recruit the ESCRT-III complex to the nuclear envelope during late anaphase (PubMed:26040712). Together with SPAST, the ESCRT-III complex promotes nuclear envelope sealing and mitotic spindle disassembly during late anaphase (PubMed:26040712). Plays a role in the endosomal sorting pathway (PubMed:16856878). {ECO:0000269|PubMed:16856878, ECO:0000269|PubMed:26040712}. |Snf7| |PspA IM30| |ESCRT III complex| |ESCRT complex disassembly| |ESCRT III complex disassembly| |exit from mitosis| |midbody abscission| |late endosome to vacuole transport| |nuclear envelope reassembly| |mitotic cytokinetic process| |viral budding via host ESCRT complex| |protein localization to chromatin| |viral budding| |multivesicular body assembly| |multivesicular body organization| |cytokinetic process| |virion assembly| |mitotic metaphase plate congression| |nuclear envelope organization| |metaphase plate congression| |protein localization to chromosome| |mitotic cytokinesis| |establishment of chromosome localization| |chromosome localization| |endosome organization| |cytoskeleton-dependent cytokinesis| |cytokinesis| |mitotic sister chromatid segregation| |chromatin| |nucleus organization| |vacuolar transport| |sister chromatid segregation| |mitotic nuclear division| |nuclear envelope| |viral life cycle| |nuclear chromosome segregation| |endosomal transport| |protein-containing complex disassembly| |mitotic cell cycle phase transition| |chromosome segregation| |cell cycle phase transition| |nuclear division| |vesicle organization| |organelle fission| |establishment of organelle localization| |cellular component disassembly| |endomembrane system organization| |cell division| |organelle localization| |mitotic cell cycle process| |mitotic cell cycle| |viral process| |protein localization to organelle| |organelle assembly| |symbiotic process| |interspecies interaction between organisms| |membrane organization| |cell cycle process| |chromosome organization| |cell cycle| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |establishment of localization in cell| |nitrogen compound transport| |protein-containing complex subunit organization| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp359|FK-506 30μM R07 exp359]]|-3.19| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-2.93| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|-2.71| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-2.53| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|-2.49| |[[:results:exp436|Dynasore 7μM R08 exp436]]|-2.38| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-2.37| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.37| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-2.31| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-2.27| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-2.21| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|-2.19| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|-2.09| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-2.09| |[[:results:exp226|Cerivastatin 0.15μM R05 exp226]]|-2.05| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.03| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-1.97| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-1.95| |[[:results:exp180|Dynasore 10μM R04 exp180]]|-1.92| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-1.85| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.85| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|-1.84| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|-1.82| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|-1.8| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-1.79| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-1.79| |[[:results:exp224|CB-839 10μM R05 exp224]]|-1.78| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-1.78| |[[:results:exp422|Wiskostatin 3μM R07 exp422]]|-1.71| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.427| Global Fraction of Cell Lines Where Essential: 112/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|5/28| |blood|1/28| |bone|5/26| |breast|9/33| |central nervous system|11/56| |cervix|1/4| |colorectal|3/17| |esophagus|1/13| |fibroblast|0/1| |gastric|3/16| |kidney|2/21| |liver|4/20| |lung|13/75| |lymphocyte|0/16| |ovary|3/26| |pancreas|6/24| |peripheral nervous system|0/16| |plasma cell|1/15| |prostate|1/1| |skin|2/24| |soft tissue|2/9| |thyroid|1/2| |upper aerodigestive|7/22| |urinary tract|5/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8181 * **Expression level (log2 read counts)**: 5.71 {{:chemogenomics:nalm6 dist.png?nolink |}}